Loading…

Purification and refolding of Escherichia coli-expressed recombinant human interleukin-2

The expression of rhIL‐2 (recombinant human interleukin‐2) in bacteria results in the formation of insoluble inclusion‐body aggregates. These aggregates were first solubilized under denaturing conditions (sodium phosphate buffer solution containing 8 M urea and 10 mM 2‐mercaptoethanol) and then puri...

Full description

Saved in:
Bibliographic Details
Published in:Biotechnology and applied biochemistry 2010-04, Vol.55 (4), p.209-214
Main Authors: Esfandiar, Samaneh, Hashemi-Najafabadi, Sameereh, Shojaosadati, Seyed Abbas, Sarrafzadeh, Shokuh Aazam, Pourpak, Zahra
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c4261-bea710032a8986c56204091b8ed1b29dd95774910f28298ab760eff1ae878cf53
cites cdi_FETCH-LOGICAL-c4261-bea710032a8986c56204091b8ed1b29dd95774910f28298ab760eff1ae878cf53
container_end_page 214
container_issue 4
container_start_page 209
container_title Biotechnology and applied biochemistry
container_volume 55
creator Esfandiar, Samaneh
Hashemi-Najafabadi, Sameereh
Shojaosadati, Seyed Abbas
Sarrafzadeh, Shokuh Aazam
Pourpak, Zahra
description The expression of rhIL‐2 (recombinant human interleukin‐2) in bacteria results in the formation of insoluble inclusion‐body aggregates. These aggregates were first solubilized under denaturing conditions (sodium phosphate buffer solution containing 8 M urea and 10 mM 2‐mercaptoethanol) and then purified using IMAC (immobilized metal‐ion‐affinity chromatography). IMAC was used to capture rhIL‐2. The protein was gradually refolded on the column by a gradient elution (8 M to 0 M urea) in the presence of 10% (v/v) glycerol. Glycerol was used to prevent protein aggregation during the refolding step. Using this method, rhIL‐2 was collected at 97% purity and its activity was measured by the lymphocyte transformation test. The measured activity was identical with commercial human interleukin‐2.
doi_str_mv 10.1042/BA20090256
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_745935681</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>745935681</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4261-bea710032a8986c56204091b8ed1b29dd95774910f28298ab760eff1ae878cf53</originalsourceid><addsrcrecordid>eNqF0MFu1DAQBmALgehSuPAAKBeEhBQ6tuPYPrartotUQQ9UrXqxHGfMmibO1k5E-_ZktUt7g5Pn8M2M5yfkPYUvFCp2dHLMADQwUb8gC1pJKJWsqpdkAUqJshKUH5A3Of8CACUVe00OGDBeg2YLcnM5peCDs2MYYmFjWyT0Q9eG-LMYfHGa3RpTcOtgCzd0ocSHTcKccevc0Dch2jgW66m3sQhxxNThdBdiyd6SV952Gd_t30NydXb6Y7kqL76ff10eX5SuYjUtG7SSAnBmlVa1EzWDCjRtFLa0YbpttZCy0hQ8U0wr28ga0HtqcT7FecEPyafd3E0a7ifMo-lDdth1NuIwZSMrobmoFf2_5FwpOX9llp930qUh5zkQs0mht-nRUDDbyM1z5DP-sB87NT22T_RvxjP4uAc2O9v5ZKML-dkxCZRJNbujnfsdOnz8x8q5PKGUbS8qdx0hj_jw1GHTnakll8Jcfzs3ZyvJ4Ha1NJf8D2OvpCc</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>733887032</pqid></control><display><type>article</type><title>Purification and refolding of Escherichia coli-expressed recombinant human interleukin-2</title><source>Wiley-Blackwell Read &amp; Publish Collection</source><creator>Esfandiar, Samaneh ; Hashemi-Najafabadi, Sameereh ; Shojaosadati, Seyed Abbas ; Sarrafzadeh, Shokuh Aazam ; Pourpak, Zahra</creator><creatorcontrib>Esfandiar, Samaneh ; Hashemi-Najafabadi, Sameereh ; Shojaosadati, Seyed Abbas ; Sarrafzadeh, Shokuh Aazam ; Pourpak, Zahra</creatorcontrib><description>The expression of rhIL‐2 (recombinant human interleukin‐2) in bacteria results in the formation of insoluble inclusion‐body aggregates. These aggregates were first solubilized under denaturing conditions (sodium phosphate buffer solution containing 8 M urea and 10 mM 2‐mercaptoethanol) and then purified using IMAC (immobilized metal‐ion‐affinity chromatography). IMAC was used to capture rhIL‐2. The protein was gradually refolded on the column by a gradient elution (8 M to 0 M urea) in the presence of 10% (v/v) glycerol. Glycerol was used to prevent protein aggregation during the refolding step. Using this method, rhIL‐2 was collected at 97% purity and its activity was measured by the lymphocyte transformation test. The measured activity was identical with commercial human interleukin‐2.</description><identifier>ISSN: 0885-4513</identifier><identifier>EISSN: 1470-8744</identifier><identifier>DOI: 10.1042/BA20090256</identifier><identifier>PMID: 20236092</identifier><identifier>CODEN: BABIEC</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Biological and medical sciences ; Biotechnology ; Chromatography, Affinity - methods ; Escherichia ; Escherichia coli - genetics ; Escherichia coli - metabolism ; Fundamental and applied biological sciences. Psychology ; His6-tagged recombinant human interleukin-2 (rhIL-2) ; Humans ; immobilized metal-ion-affinity chromatography (IMAC) ; Inclusion Bodies - metabolism ; Interleukin-2 - biosynthesis ; Interleukin-2 - chemistry ; Interleukin-2 - genetics ; Interleukin-2 - isolation &amp; purification ; lymphocyte transformation test (LTT) ; metal-affinity chromatography purification ; Ni2+-nitrilotriacetate-agarose (Ni-NTA-agarose) ; Nitrilotriacetic Acid - analogs &amp; derivatives ; Nitrilotriacetic Acid - chemistry ; Organometallic Compounds - chemistry ; Protein Folding ; Recombinant Proteins - biosynthesis ; Recombinant Proteins - chemistry ; Recombinant Proteins - genetics ; Recombinant Proteins - isolation &amp; purification ; refolding ; Solubility</subject><ispartof>Biotechnology and applied biochemistry, 2010-04, Vol.55 (4), p.209-214</ispartof><rights>2010 International Union of Biochemistry and Molecular Biology</rights><rights>2015 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4261-bea710032a8986c56204091b8ed1b29dd95774910f28298ab760eff1ae878cf53</citedby><cites>FETCH-LOGICAL-c4261-bea710032a8986c56204091b8ed1b29dd95774910f28298ab760eff1ae878cf53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=22701278$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20236092$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Esfandiar, Samaneh</creatorcontrib><creatorcontrib>Hashemi-Najafabadi, Sameereh</creatorcontrib><creatorcontrib>Shojaosadati, Seyed Abbas</creatorcontrib><creatorcontrib>Sarrafzadeh, Shokuh Aazam</creatorcontrib><creatorcontrib>Pourpak, Zahra</creatorcontrib><title>Purification and refolding of Escherichia coli-expressed recombinant human interleukin-2</title><title>Biotechnology and applied biochemistry</title><addtitle>Biotechnol Appl Biochem</addtitle><description>The expression of rhIL‐2 (recombinant human interleukin‐2) in bacteria results in the formation of insoluble inclusion‐body aggregates. These aggregates were first solubilized under denaturing conditions (sodium phosphate buffer solution containing 8 M urea and 10 mM 2‐mercaptoethanol) and then purified using IMAC (immobilized metal‐ion‐affinity chromatography). IMAC was used to capture rhIL‐2. The protein was gradually refolded on the column by a gradient elution (8 M to 0 M urea) in the presence of 10% (v/v) glycerol. Glycerol was used to prevent protein aggregation during the refolding step. Using this method, rhIL‐2 was collected at 97% purity and its activity was measured by the lymphocyte transformation test. The measured activity was identical with commercial human interleukin‐2.</description><subject>Biological and medical sciences</subject><subject>Biotechnology</subject><subject>Chromatography, Affinity - methods</subject><subject>Escherichia</subject><subject>Escherichia coli - genetics</subject><subject>Escherichia coli - metabolism</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>His6-tagged recombinant human interleukin-2 (rhIL-2)</subject><subject>Humans</subject><subject>immobilized metal-ion-affinity chromatography (IMAC)</subject><subject>Inclusion Bodies - metabolism</subject><subject>Interleukin-2 - biosynthesis</subject><subject>Interleukin-2 - chemistry</subject><subject>Interleukin-2 - genetics</subject><subject>Interleukin-2 - isolation &amp; purification</subject><subject>lymphocyte transformation test (LTT)</subject><subject>metal-affinity chromatography purification</subject><subject>Ni2+-nitrilotriacetate-agarose (Ni-NTA-agarose)</subject><subject>Nitrilotriacetic Acid - analogs &amp; derivatives</subject><subject>Nitrilotriacetic Acid - chemistry</subject><subject>Organometallic Compounds - chemistry</subject><subject>Protein Folding</subject><subject>Recombinant Proteins - biosynthesis</subject><subject>Recombinant Proteins - chemistry</subject><subject>Recombinant Proteins - genetics</subject><subject>Recombinant Proteins - isolation &amp; purification</subject><subject>refolding</subject><subject>Solubility</subject><issn>0885-4513</issn><issn>1470-8744</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNqF0MFu1DAQBmALgehSuPAAKBeEhBQ6tuPYPrartotUQQ9UrXqxHGfMmibO1k5E-_ZktUt7g5Pn8M2M5yfkPYUvFCp2dHLMADQwUb8gC1pJKJWsqpdkAUqJshKUH5A3Of8CACUVe00OGDBeg2YLcnM5peCDs2MYYmFjWyT0Q9eG-LMYfHGa3RpTcOtgCzd0ocSHTcKccevc0Dch2jgW66m3sQhxxNThdBdiyd6SV952Gd_t30NydXb6Y7kqL76ff10eX5SuYjUtG7SSAnBmlVa1EzWDCjRtFLa0YbpttZCy0hQ8U0wr28ga0HtqcT7FecEPyafd3E0a7ifMo-lDdth1NuIwZSMrobmoFf2_5FwpOX9llp930qUh5zkQs0mht-nRUDDbyM1z5DP-sB87NT22T_RvxjP4uAc2O9v5ZKML-dkxCZRJNbujnfsdOnz8x8q5PKGUbS8qdx0hj_jw1GHTnakll8Jcfzs3ZyvJ4Ha1NJf8D2OvpCc</recordid><startdate>201004</startdate><enddate>201004</enddate><creator>Esfandiar, Samaneh</creator><creator>Hashemi-Najafabadi, Sameereh</creator><creator>Shojaosadati, Seyed Abbas</creator><creator>Sarrafzadeh, Shokuh Aazam</creator><creator>Pourpak, Zahra</creator><general>Blackwell Publishing Ltd</general><general>Wiley</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>7QL</scope><scope>7QO</scope><scope>7T5</scope><scope>7T7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>P64</scope></search><sort><creationdate>201004</creationdate><title>Purification and refolding of Escherichia coli-expressed recombinant human interleukin-2</title><author>Esfandiar, Samaneh ; Hashemi-Najafabadi, Sameereh ; Shojaosadati, Seyed Abbas ; Sarrafzadeh, Shokuh Aazam ; Pourpak, Zahra</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4261-bea710032a8986c56204091b8ed1b29dd95774910f28298ab760eff1ae878cf53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>Biological and medical sciences</topic><topic>Biotechnology</topic><topic>Chromatography, Affinity - methods</topic><topic>Escherichia</topic><topic>Escherichia coli - genetics</topic><topic>Escherichia coli - metabolism</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>His6-tagged recombinant human interleukin-2 (rhIL-2)</topic><topic>Humans</topic><topic>immobilized metal-ion-affinity chromatography (IMAC)</topic><topic>Inclusion Bodies - metabolism</topic><topic>Interleukin-2 - biosynthesis</topic><topic>Interleukin-2 - chemistry</topic><topic>Interleukin-2 - genetics</topic><topic>Interleukin-2 - isolation &amp; purification</topic><topic>lymphocyte transformation test (LTT)</topic><topic>metal-affinity chromatography purification</topic><topic>Ni2+-nitrilotriacetate-agarose (Ni-NTA-agarose)</topic><topic>Nitrilotriacetic Acid - analogs &amp; derivatives</topic><topic>Nitrilotriacetic Acid - chemistry</topic><topic>Organometallic Compounds - chemistry</topic><topic>Protein Folding</topic><topic>Recombinant Proteins - biosynthesis</topic><topic>Recombinant Proteins - chemistry</topic><topic>Recombinant Proteins - genetics</topic><topic>Recombinant Proteins - isolation &amp; purification</topic><topic>refolding</topic><topic>Solubility</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Esfandiar, Samaneh</creatorcontrib><creatorcontrib>Hashemi-Najafabadi, Sameereh</creatorcontrib><creatorcontrib>Shojaosadati, Seyed Abbas</creatorcontrib><creatorcontrib>Sarrafzadeh, Shokuh Aazam</creatorcontrib><creatorcontrib>Pourpak, Zahra</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Immunology Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Biotechnology and BioEngineering Abstracts</collection><jtitle>Biotechnology and applied biochemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Esfandiar, Samaneh</au><au>Hashemi-Najafabadi, Sameereh</au><au>Shojaosadati, Seyed Abbas</au><au>Sarrafzadeh, Shokuh Aazam</au><au>Pourpak, Zahra</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Purification and refolding of Escherichia coli-expressed recombinant human interleukin-2</atitle><jtitle>Biotechnology and applied biochemistry</jtitle><addtitle>Biotechnol Appl Biochem</addtitle><date>2010-04</date><risdate>2010</risdate><volume>55</volume><issue>4</issue><spage>209</spage><epage>214</epage><pages>209-214</pages><issn>0885-4513</issn><eissn>1470-8744</eissn><coden>BABIEC</coden><abstract>The expression of rhIL‐2 (recombinant human interleukin‐2) in bacteria results in the formation of insoluble inclusion‐body aggregates. These aggregates were first solubilized under denaturing conditions (sodium phosphate buffer solution containing 8 M urea and 10 mM 2‐mercaptoethanol) and then purified using IMAC (immobilized metal‐ion‐affinity chromatography). IMAC was used to capture rhIL‐2. The protein was gradually refolded on the column by a gradient elution (8 M to 0 M urea) in the presence of 10% (v/v) glycerol. Glycerol was used to prevent protein aggregation during the refolding step. Using this method, rhIL‐2 was collected at 97% purity and its activity was measured by the lymphocyte transformation test. The measured activity was identical with commercial human interleukin‐2.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>20236092</pmid><doi>10.1042/BA20090256</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0885-4513
ispartof Biotechnology and applied biochemistry, 2010-04, Vol.55 (4), p.209-214
issn 0885-4513
1470-8744
language eng
recordid cdi_proquest_miscellaneous_745935681
source Wiley-Blackwell Read & Publish Collection
subjects Biological and medical sciences
Biotechnology
Chromatography, Affinity - methods
Escherichia
Escherichia coli - genetics
Escherichia coli - metabolism
Fundamental and applied biological sciences. Psychology
His6-tagged recombinant human interleukin-2 (rhIL-2)
Humans
immobilized metal-ion-affinity chromatography (IMAC)
Inclusion Bodies - metabolism
Interleukin-2 - biosynthesis
Interleukin-2 - chemistry
Interleukin-2 - genetics
Interleukin-2 - isolation & purification
lymphocyte transformation test (LTT)
metal-affinity chromatography purification
Ni2+-nitrilotriacetate-agarose (Ni-NTA-agarose)
Nitrilotriacetic Acid - analogs & derivatives
Nitrilotriacetic Acid - chemistry
Organometallic Compounds - chemistry
Protein Folding
Recombinant Proteins - biosynthesis
Recombinant Proteins - chemistry
Recombinant Proteins - genetics
Recombinant Proteins - isolation & purification
refolding
Solubility
title Purification and refolding of Escherichia coli-expressed recombinant human interleukin-2
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T11%3A43%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Purification%20and%20refolding%20of%20Escherichia%20coli-expressed%20recombinant%20human%20interleukin-2&rft.jtitle=Biotechnology%20and%20applied%20biochemistry&rft.au=Esfandiar,%20Samaneh&rft.date=2010-04&rft.volume=55&rft.issue=4&rft.spage=209&rft.epage=214&rft.pages=209-214&rft.issn=0885-4513&rft.eissn=1470-8744&rft.coden=BABIEC&rft_id=info:doi/10.1042/BA20090256&rft_dat=%3Cproquest_cross%3E745935681%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4261-bea710032a8986c56204091b8ed1b29dd95774910f28298ab760eff1ae878cf53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=733887032&rft_id=info:pmid/20236092&rfr_iscdi=true